The Valley Desk

NCT06338995 · Interventional trial

A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)

Overall registry status Recruiting

Phase 3

Conditions Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov